MedTrace Logo

Study on the Chronic and Acute Effects of Nordic Berry Beverage on Cognitive Function

NCT05693441 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2023-07-06

No results posted yet for this study

Summary

The aim of the current study is to investigate whether acute and 12-weeks daily intake of Nordic berries can improve cognitive abilities of adults without cognitive disease, and whether the effect can be linked to changes in metabolic parameters.

Conditions

  • Age-related Cognitive Decline

Interventions

OTHER

Active berry product

Subjects should consume the active product containing nordic berries daily during the 12 week intervention period.

OTHER

Reference berry-like product

Subjects should consume a reference product (isocaloric to active product, containing berry aromas and colouring but no actual berry compounds) daily during the 12 week intervention period.

Sponsors & Collaborators

  • Berry Lab AB

    collaborator UNKNOWN

  • Aventure AB

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-17
Primary Completion
2023-06-22
Completion
2023-06-22

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05693441 on ClinicalTrials.gov